Literature DB >> 26453750

NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors.

Olga M Anton1, Susina Vielkind1, Mary E Peterson1, Yutaka Tagaya2, Eric O Long3.   

Abstract

IL-15 bound to the IL-15Rα-chain (IL-15Rα) is presented in trans to cells bearing the IL-2Rβ-chain and common γ-chain. As IL-15 transpresentation occurs in the context of cell-to-cell contacts, it has the potential for regulation by and of other receptor-ligand interactions. In this study, human NK cells were tested for the sensitivity of IL-15 transpresentation to inhibitory receptors. Human cells expressing HLA class I ligands for inhibitory receptors KIR2DL1, KIR2DL2/3, or CD94-NKG2A were transfected with IL-15Rα. Proliferation of primary NK cells in response to transpresented IL-15 was reduced by engagement of either KIR2DL1 or KIR2DL2/3 by cognate HLA-C ligands. Inhibitory KIR-HLA-C interactions did not reduce the proliferation induced by soluble IL-15. Therefore, transpresentation of IL-15 is subject to downregulation by MHC class I-specific inhibitory receptors. Similarly, proliferation of the NKG2A(+) cell line NKL induced by IL-15 transpresentation was inhibited by HLA-E. Coengagement of inhibitory receptors, either KIR2DL1 or CD94-NKG2A, did not inhibit phosphorylation of Stat5 but inhibited selectively phosphorylation of Akt and S6 ribosomal protein. IL-15Rα was not excluded from, but was evenly distributed across, inhibitory synapses. These findings demonstrate a novel mechanism to attenuate IL-15-dependent NK cell proliferation and suggest that inhibitory NK cell receptors contribute to NK cell homeostasis.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26453750      PMCID: PMC4637193          DOI: 10.4049/jimmunol.1500414

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells.

Authors:  Sigrid Dubois; Jennifer Mariner; Thomas A Waldmann; Yutaka Tagaya
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

Review 2.  The Jak-STAT pathway.

Authors:  K Imada; W J Leonard
Journal:  Mol Immunol       Date:  2000 Jan-Feb       Impact factor: 4.407

3.  Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

Authors:  D N Burshtyn; J Shin; C Stebbins; E O Long
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

Review 4.  Intersection of mTOR and STAT signaling in immunity.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Trends Immunol       Date:  2014-11-15       Impact factor: 16.687

5.  Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.

Authors:  Guido Ferlazzo; Ming L Tsang; Lorenzo Moretta; Giovanni Melioli; Ralph M Steinman; Christian Münz
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

6.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

7.  Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.

Authors:  Rima Koka; Patrick R Burkett; Marcia Chien; Sophia Chai; Faye Chan; James P Lodolce; David L Boone; Averil Ma
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

8.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

Authors:  R Biassoni; C Cantoni; M Falco; S Verdiani; C Bottino; M Vitale; R Conte; A Poggi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity.

Authors:  K Imada; E T Bloom; H Nakajima; J A Horvath-Arcidiacono; G B Udy; H W Davey; W J Leonard
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

10.  The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.

Authors:  Julien Cherfils-Vicini; Charlotte Viant; Antoine Marçais; Sophie Degouve; Sébastien Viel; Aurore Fenis; Jessica Rabilloud; Katia Mayol; Armelle Tavares; Jacques Bienvenu; Yann-Gaël Gangloff; Eric Gilson; Eric Vivier; Thierry Walzer
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

View more
  9 in total

1.  In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.

Authors:  Takafumi Yagisawa; Toshiaki Tanaka; Satoshi Miyairi; Kazunari Tanabe; Nina Dvorina; Wayne M Yokoyama; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2018-11-29       Impact factor: 10.612

2.  Trans-endocytosis of intact IL-15Rα-IL-15 complex from presenting cells into NK cells favors signaling for proliferation.

Authors:  Olga M Anton; Mary E Peterson; Michael J Hollander; David W Dorward; Gunjan Arora; Javier Traba; Sumati Rajagopalan; Erik L Snapp; K Christopher Garcia; Thomas A Waldmann; Eric O Long
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

3.  Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.

Authors:  Laurent Gorvel; Daniel Korenfeld; Thomas Tung; Eynav Klechevsky
Journal:  J Immunol       Date:  2017-07-12       Impact factor: 5.422

4.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Anna Rünzi; Tanja Kuhlmann; Anita Posevitz-Fejfár; Nicholas Schwab; Tilman Schneider-Hohendorf; Sebastian Herich; Kathrin Held; Matea Konjević; Marvin Hartwig; Klaus Dornmair; Reinhard Hohlfeld; Tjalf Ziemssen; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

5.  Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression.

Authors:  Avishai Shemesh; Yapeng Su; Daniel R Calabrese; Daniel Chen; Janice Arakawa-Hoyt; Kole T Roybal; James R Heath; John R Greenland; Lewis L Lanier
Journal:  J Exp Med       Date:  2022-09-06       Impact factor: 17.579

6.  Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells.

Authors:  Thuy Thanh Luu; Sridharan Ganesan; Arnika Kathleen Wagner; Dhifaf Sarhan; Stephan Meinke; Natalio Garbi; Günter Hämmerling; Evren Alici; Klas Kärre; Benedict J Chambers; Petter Höglund; Nadir Kadri
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

Review 7.  Transcription Factors Associated With IL-15 Cytokine Signaling During NK Cell Development.

Authors:  Xiang Wang; Xiang-Yu Zhao
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

8.  Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Authors:  Yanling Xiao; Harry Dolstra; Willemijn Hobo; Jesper van Eck van der Sluijs; Diede van Ens; Soley Thordardottir; Denise Vodegel; Inge Hermens; Anniek B van der Waart; J H Frederik Falkenburg; Michel G D Kester; Iris de Rink; Mirjam H M Heemskerk; Jannie Borst; Nicolaas P M Schaap; Joop H Jansen
Journal:  Cancer Immunol Immunother       Date:  2021-04-01       Impact factor: 6.968

9.  Remodeling of secretory lysosomes during education tunes functional potential in NK cells.

Authors:  Jodie P Goodridge; Benedikt Jacobs; Michelle L Saetersmoen; Dennis Clement; Quirin Hammer; Trevor Clancy; Ellen Skarpen; Andreas Brech; Johannes Landskron; Christian Grimm; Aline Pfefferle; Leonardo Meza-Zepeda; Susanne Lorenz; Merete Thune Wiiger; William E Louch; Eivind Heggernes Ask; Lisa L Liu; Vincent Yi Sheng Oei; Una Kjällquist; Sten Linnarsson; Sandip Patel; Kjetil Taskén; Harald Stenmark; Karl-Johan Malmberg
Journal:  Nat Commun       Date:  2019-01-31       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.